|

| 产地 | France |
| 品牌 | AntibodySystem |
| 货号 | YHB98501 |
| 用途 | 仅用于科研 |
| 包装规格 | 100 μg |
| 纯度 | 0.95% |
| CAS编号 | |
| 是否进口 | 否 |
| 货号 | YHB98501 |
| 产品名称 | Recombinant Human APOA1 Protein, N-His |
| 规格 | 100 μg |
| 价格 | 1880 |
| 状态 | Lyophilized |
| 储存缓冲液 | Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol. |
| 纯度 | >90% as determined by SDS-PAGE. |
| 应用 | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| 内毒水平 | Please contact with the lab for this information. |
| 表达系统 | E. coli |
| Accession | P02647 |
| 蛋白长度 | Arg19-Gln267 |
| 预测分子量 | 31.27 kDa |
| 稳定性与储存条件 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 重悬 | Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details. |
| 别名 | ApoA-I, ProapoA-I, Apolipoprotein A1, Apo-AI, Apolipoprotein A-I, APOA1, Apolipoprotein A-I(1-242) |
| 物种 | Homo sapiens (Human) |
| 运输 | In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
| 备注 | For research use only. |
APOA1(载脂蛋白 A1)是脂质转运核心蛋白,介导外周胆固醇逆向转运,维护脂质稳态、保护内皮,主要由肝脏与小肠合成。表达紊乱易造成脂质代谢失衡,是脂代谢调控、脉管稳态研究常用靶点。
Q1:APOA1 重组蛋白制备规格?
A:大肠杆菌表达、N‑His 标签,分子量 31.27 kDa,SDS‑PAGE 纯度>90%。
Q2:冻干蛋白复溶方式?
A:无菌纯水调配储备液,详细操作参照配套数据表。
Q3:储存方案与保质期?
A:频繁使用 2~8℃存放,长期‑20~‑80℃保存,有效期 12 个月,防止反复冻融。
Q4:应用场景与使用要求?
A:可做 WB、ELISA、免疫原制备,活性处于验证阶段,仅用于科研
前沿相关研究:
1.Apolipoprotein and sphingolipid measurements: Can be used in the clinical practice of atrial fibrillation diagnosing and evaluating the cryoablation effectiveness?, PMID:40036186
2.The Relationship Between Serum SFRP5, ApoA-I, HDL3-C Level and In-Stent Restenosis After PCI in Acute Myocardial Infarction and the Combined Predictive Value., PMID:40056066
3.Integrating network pharmacology, quantitative transcriptomic analysis, and experimental validation revealed the mechanism of cordycepin in the treatment of obesity., PMID:40438591
4.Identification of Potential Functional Modules and Diagnostic Genes for Crohn's Disease Based on Weighted Gene Co-expression Network Analysis and LASSO Algorithm., PMID:40181741
5.Potential of CETP inhibition in treating dyslipidemia in systemic lupus erythematosus: Novel and comprehensive evidence from clinical studies and Mendelian randomization., PMID:40315629
6.Induction of SOX17 with stimulation of WNT, TGF-beta, and FGF signaling drives embryonal carcinomas into the yolk-sac tumor lineage resulting in increased cisplatin resistance., PMID:40025812
7.Correlation of glycosylated apolipoprotein A1 and glycosylated low-density lipoprotein cholesterol levels with glucose homeostasis and the risk of developing type 2 diabetes mellitus., PMID:40185244